by Sarah Avery, Duke University Graphical abstract. Credit: Nature Chemical Biology (2022). DOI: 10.1038/s41589-022-01094-4 In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections. The proof-of-concept experiments, conducted in mice, modified a currently available lipid nanoparticle to deliver...
